![Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances](https://www.science.org/cms/10.1126/sciadv.abq6527/asset/4169c14e-2075-482d-9852-59f2eac1dd6a/assets/images/large/sciadv.abq6527-f1.jpg)
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances
![A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25331-x/MediaObjects/41467_2021_25331_Fig1_HTML.png)
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
![Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6ca7887f-d867-4d10-9e0e-bbea705c83a6/fx1_lrg.jpg)
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
![Frontiers | Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention Frontiers | Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention](https://www.frontiersin.org/files/Articles/690976/fimmu-12-690976-HTML/image_m/fimmu-12-690976-g001.jpg)
Frontiers | Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://www.thelancet.com/cms/asset/1c286603-5a7d-4bb9-a109-6d1568197364/gr1.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
![Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/ff3b1786-68d5-4dd4-bc5d-74d2ac3babc4/gr1_lrg.jpg)